News - Roche, Licensing

Filter

Current filters:

RocheLicensing

Popular Filters

1 to 25 of 42 results

Roche in deal with Oryzon to develop epigenetics-based medicines; Buys IQuum

Roche in deal with Oryzon to develop epigenetics-based medicines; Buys IQuum

07-04-2014

Swiss drug major Roche has entered to a worldwide collaboration with Spanish functional genomics firm…

BiotechnologyIQuumLicensingMergers & AcquisitionsOncologyORY-1001Oryzon GenomicsRoche

Xenon and Genentech establish new pain discovery collaboration

26-03-2014

Privately-held US biotech firm Xenon Pharmaceuticals has established a new collaboration with Swiss drug…

BiotechnologyGenentechLicensingNeurologicalResearchRocheXenon Pharmaceuticals

Roche collaborates with Discuva to combat life-threatening infections

28-02-2014

Swiss pharma major Roche and privately-held UK biotech firm Discuva have entered into a worldwide collaboration…

Antibiotics and Infectious diseasesDiscuvaLicensingPharmaceuticalResearchRoche

Prothena to get $30 million upfront from Roche triggered by regulatory milestone

Prothena to get $30 million upfront from Roche triggered by regulatory milestone

23-01-2014

Clinical-stage biotech firm Prothena said today that it will receive the $30 million upfront payment…

BiotechnologyFinancialLicensingNeurologicalProthenaPRX002Roche

Santaris inks deal with Roche for RNA-targeted medicines

Santaris inks deal with Roche for RNA-targeted medicines

09-01-2014

Danish privately held clinical-stage biopharmaceutical company Santaris Pharma has signed a worldwide…

LicensingPharmaceuticalResearchRocheSantaris Pharma

Prothena inks deal with Roche, worth a potential $600 million

Prothena inks deal with Roche, worth a potential $600 million

12-12-2013

Biotech firm Prothena has entered into a worldwide collaboration with Swiss drug major Roche to develop…

BiotechnologyGlobalLicensingNeurologicalProthenaPRX002ResearchRoche

Roche to pay initial 55 million-francs for deal with Molecular Partners

Roche to pay initial 55 million-francs for deal with Molecular Partners

04-12-2013

Swiss drug major Roche has linked up with Switzerland-based privately held biotech firm Molecular Partners…

BiotechnologyLicensingMolecular PartnersOncologyResearchRoche

Chugai unit seals deal for Helsinn’s anamorelin in top EU markets

12-11-2013

Privately-held Swiss pharmaceutical group Helsinn has granted Chugai Pharma Marketing, a wholly-owned…

anamorelinChugai PharmaceuticalEuropeHelsinnLicensingOncologyPharmaceuticalRoche

Roche in-licenses POL7080 from Polyphor in up to 500 million-franc accord

Roche in-licenses POL7080 from Polyphor in up to 500 million-franc accord

04-11-2013

Drug major Roche has entered into an exclusive worldwide license agreement to develop and commercialize…

Antibiotics and Infectious diseasesLicensingPharmaceuticalPOL7080PolyphorRoche

Roche's subcutaneous Herceptin injection approved for use in UK

Roche's subcutaneous Herceptin injection approved for use in UK

24-09-2013

From today HER2-positive breast cancer patients in the UK could benefit from a faster, more efficient…

EuropeHerceptinLicensingOncologyPharmaceuticalRoche

Roche in up to $422.5 million deal with Inovio Pharma

11-09-2013

Swiss drug major Roche (ROG: SIX) has signed an exclusive, worldwide license agreement with US drug developer…

Anti-viralsINO-1800INO-5150Inovio PharmaceuticalsLicensingOncologyPharmaceuticalRoche

Biocad enters deal for exporting rituximab biosimilar to Turkey

22-08-2013

Biocad, one of Russia's leading biotechnology companies, has signed a definitive agreement on the export…

BiocadBiotechnologyEuropeGenericsKocak FarmaLicensingMabTheraMarkets & MarketingOncologyRituxanrituximabRoche

Russia's R-Pharm to develop UCB's olokizumab for rheumatoid arthritis

04-07-2013

Belgium's leading pharma company UCB (Euronext Brussels: UCB) said today (July 4) that it has granted…

Anti-Arthritics/RheumaticsLicensingolokizumabPharmaceuticalR-PharmaRoActemraRocheUCB

Immunocore and Genentech collaborate to develop ImmTACs for multiple cancer targets

01-07-2013

Immunocore, an Oxford, UK-based biotechnology company developing novel biological drugs known as ImmTACs…

BiotechnologyGenentechLicensingOncologyResearchRoche

Roche teams up with Ascletis on hep C treatments for China

15-04-2013

Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

Roche and Isis Pharma in up to $392 million deal on Huntington's research

09-04-2013

Swiss drug major Roche (ROG: SIX) and USA-based Isis Pharmaceuticals (Nasdaq: ISIS) have formed an alliance…

Isis PharmaceuticalsLicensingMarkets & MarketingPharmaceuticalRare diseasesResearchRoche

Roche pulls out of fibrosis alliance with Galapagos

11-03-2013

Belgium-based Galapagos (Euronext Brussels: GLPG) revealed that Swiss drug major Roche (ROG: SIX) has…

GalapagosLicensingPharmaceuticalRespiratory and PulmonaryRoche

Genentech enters $111 million drug discovery pact with RQx Pharma

13-02-2013

California, USA-based privately-held RQx Pharmaceuticals said yesterday that it has entered into a drug…

BiotechnologyGenentechLicensingRocheRQx Pharmaceuticals

Curis in-licenses cancer candidate from Genentech

30-11-2012

US drug development firm Curis (Nasdaq: CRIS) that it has licensed from Genentech, a subsidiary of Swiss…

BiotechnologyCurisGDC-0917GenentechGUDC-427LicensingOncologyPharmaceuticalRoche

Chugai in co-development accord for obinutuzumab with Nippon Shinyaku

28-11-2012

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519), which is majority-owned by Swiss drug major Roche…

BiotechnologyChugai PharmaceuticalLicensingNippon ShinyakuobinutuzumabOncologyPharmaceuticalResearchrituximabRoche

Chugai licenses SGLT2 inhibitor CSG452 in Japan to Kowa and Sanofi

29-10-2012

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519), which is majority owned by Swiss major Roche (ROG:…

Asia-PacificChugai PharmaceuticalCSG452DiabetesKowa PharmaceuticalsLicensingPharmaceuticalRocheSanofi

1 to 25 of 42 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top